| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.07.25 | EnChannel Medical Ltd.: EnChannel Medical to Acquire Acutus Medical AcQMap Electrophysiology Assets | 437 | PR Newswire | IRVINE, Calif., July 1, 2025 /PRNewswire/ -- EnChannel Medical Ltd., a global leader in cardiac electrophysiology innovation, today announced it has signed a definitive agreement to acquire... ► Artikel lesen | |
| ACUTUS MEDICAL Aktie jetzt für 0€ handeln | |||||
| 24.03.25 | Acutus Medical, Inc.: Acutus Medical Reports Full Year 2024 Financial Results | 324 | GlobeNewswire (Europe) | CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 4,410 | -0,03 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 | ||
| NUGEN MEDICAL DEVICES | 0,016 | -6,90 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| UNIDOC HEALTH | 0,066 | -13,37 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| ORGANON | 5,834 | -1,09 % | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| FRESENIUS | 47,550 | -1,31 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Falko Friedrichs lobte in seiner am Donnerstag vorliegenden... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,860 | -1,77 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,110 | -1,37 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,130 | -0,05 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen | |
| PROGYNY | 17,800 | +1,60 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| PROCEPT BIOROBOTICS | 26,600 | +2,62 % | Truist cuts Procept BioRobotics stock price target on lower forecasts | ||
| LIFESTANCE HEALTH GROUP | 7,325 | +2,45 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 23,910 | +2,44 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| INNOVAGE | 10,610 | +14,46 % | InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025 | DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| NEUROPACE | 13,960 | -1,34 % | Why NeuroPace Stock Was Inching Higher on Wednesday | ||
| PRIVIA HEALTH GROUP | 24,310 | +1,21 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen |